Arrowhead Pharmaceuticals Insider Trades (NASDAQ:ARWR)

$44.42

-0.19 (-0.43 %)

(As of 01/27/2020 01:43 PM ET)

Add

Compare

Today's Range

$42.39

Now: $44.42▼

$44.80

50-Day Range

$44.61

MA: $61.53▼

$70.86

52-Week Range

$12.72

Now: $44.42▼

$73.72

Volume1.03 million shs

Average Volume1.65 million shs

Market Capitalization$4.25 billion

P/E Ratio64.38

Dividend YieldN/A

Beta1.97

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.80%

Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals (NASDAQ ARWR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/21/2020	Kenneth Allen Myszkowski	CFO	Sell	40,313	$49.44	$1,993,074.72	424,536
1/6/2020	Bruce D Given	COO	Sell	35,613	$60.13	$2,141,409.69	882,759
1/6/2020	Kenneth Allen Myszkowski	CFO	Sell	20,000	$60.11	$1,202,200.00	403,592
1/6/2020	Patrick O'brien	General Counsel	Sell	14,625	$60.12	$879,255.00	267,406
12/12/2019	Christopher Richard Anzalone	CEO	Sell	100,000	$67.50	$6,750,000.00	2,048,684
12/2/2019	Christopher Richard Anzalone	CEO	Sell	37,967	$69.15	$2,625,418.05	2,116,160
11/1/2019	Kenneth Allen Myszkowski	CFO	Sell	37,884	$40.85	$1,547,561.40	351,420
10/10/2019	Christopher Richard Anzalone	CEO	Sell	56,325	$31.83	$1,792,824.75	2,178,228
9/24/2019	Christopher Richard Anzalone	CEO	Sell	66,645	$28.20	$1,879,389.00	2,146,153
9/20/2019	Christopher Richard Anzalone	CEO	Sell	4,250	$29.00	$123,250.00	2,146,153
9/11/2019	Michael S Perry	Director	Sell	85,000	$30.00	$2,550,000.00	121,000
9/9/2019	Michael S Perry	Director	Sell	100,000	$28.90	$2,890,000.00	121,000
6/26/2019	Mauro Ferrari	Director	Sell	17,756	$27.61	$490,243.16	1,900
5/28/2019	Patrick O'brien	General Counsel	Sell	30,000	$24.88	$746,400.00	203,000
5/21/2019	Kenneth Allen Myszkowski	CFO	Sell	27,071	$22.00	$595,562.00	278,536
4/3/2019	Christopher Richard Anzalone	CEO	Sell	50,000	$19.30	$965,000.00
3/1/2019	Bruce D Given	COO	Sell	42,500	$19.99	$849,575.00	687,106
2/26/2019	Douglas B Given	Director	Sell	65,000	$19.25	$1,251,250.00	175,130
2/25/2019	Bruce D Given	COO	Sell	42,500	$18.98	$806,650.00	687,106
2/22/2019	Douglas B Given	Director	Sell	3,000	$18.05	$54,150.00	175,130
2/19/2019	Bruce D Given	COO	Sell	68,750	$17.86	$1,227,875.00	644,606
2/19/2019	Kenneth Allen Myszkowski	CFO	Sell	8,000	$18.00	$144,000.00	313,607
2/15/2019	Bruce D Given	COO	Sell	26,250	$17.67	$463,837.50	644,606
2/12/2019	Bruce D Given	COO	Sell	242,834	$16.04	$3,895,057.36	859,523
2/8/2019	Bruce D Given	COO	Sell	46,167	$15.34	$708,201.78	859,523
2/5/2019	Bruce D Given	COO	Sell	22,500	$14.48	$325,800.00	847,856
2/1/2019	Bruce D Given	COO	Sell	28,500	$13.85	$394,725.00	870,356
1/23/2019	Bruce D Given	COO	Sell	169,500	$13.54	$2,295,030.00	916,356
1/22/2019	Douglas B Given	Director	Sell	3,000	$13.58	$40,740.00	178,130
1/18/2019	Patrick O'brien	General Counsel	Sell	72,000	$14.43	$1,038,960.00	233,000
1/17/2019	Kenneth Allen Myszkowski	CFO	Sell	81,875	$14.55	$1,191,281.25	305,607
1/14/2019	Bruce D Given	COO	Sell	42,666	$14.40	$614,390.40	1,110,022
1/14/2019	Zhen Li	VP	Sell	40,500	$14.34	$580,770.00	201,700
1/11/2019	William D Waddill	Director	Sell	8,500	$14.77	$125,545.00	46,500
1/2/2019	Bruce D Given	COO	Sell	20,000	$11.98	$239,600.00	1,118,356
1/2/2019	Kenneth Allen Myszkowski	CFO	Sell	8,333	$11.98	$99,829.34	395,815
12/27/2018	Douglas B. Given	Director	Sell	3,000	$12.00	$36,000.00
12/19/2018	Christopher Richard Anzalone	CEO	Sell	90,000	$13.92	$1,252,800.00
12/12/2018	Christopher Richard Anzalone	CEO	Sell	90,000	$14.07	$1,266,300.00
11/23/2018	Douglas B. Given	Director	Sell	3,000	$12.74	$38,220.00
11/9/2018	Christopher Richard Anzalone	CEO	Sell	81,500	$14.39	$1,172,785.00	1,727,755
10/19/2018	Peter Brian Leone	VP	Sell	131,137	$13.49	$1,769,038.13	160,000
9/6/2018	Kenneth Allen Myszkowski	CFO	Sell	45,000	$19.34	$870,300.00	335,815
9/4/2018	Christopher Richard Anzalone	CEO	Sell	164,834	$14.45	$2,381,851.30	1,868,789
8/31/2018	Christopher Richard Anzalone	CEO	Sell	100,000	$14.45	$1,445,000.00	1,868,789
6/19/2018	Kenneth Allen Myszkowski	CFO	Sell	20,000	$14.01	$280,200.00	330,815
5/31/2018	Kenneth Allen Myszkowski	CFO	Sell	14,000	$11.00	$154,000.00	312,215
4/24/2018	Douglas B. Given	Director	Sell	25,000	$6.63	$165,750.00
3/27/2018	Kenneth Allen Myszkowski	CFO	Sell	20,000	$8.00	$160,000.00	330,815
3/15/2018	Christopher Richard Anzalone	CEO	Sell	300,000	$7.43	$2,229,000.00	2,194,789
3/13/2018	Christopher Richard Anzalone	CEO	Sell	100,000	$7.43	$743,000.00	2,194,789
3/5/2018	Bruce D Given	COO	Sell	20,000	$6.73	$134,600.00	908,356
1/1/2018	Bruce D Given	COO	Sell	20,000	$3.69	$73,800.00	948,356
10/14/2016	Douglas B. Given	Director	Sell	12,000	$6.72	$80,640.00
8/23/2016	Kenneth Allen Myszkowski	CFO	Sell	6,900	$8.00	$55,200.00	128,789
8/22/2016	Kenneth Allen Myszkowski	CFO	Sell	13,100	$8.00	$104,800.00	128,789
12/30/2015	Kenneth Allen Myszkowski	CFO	Sell	23,347	$6.13	$143,117.11	135,000
10/28/2015	Mauro Ferrari	Director	Buy	400	$7.62	$3,048.00
10/9/2015	Mauro Ferrari	Director	Buy	1,900	$6.19	$11,761.00
1/5/2015	David L Lewis	Insider	Sell	15,000	$8.01	$120,150.00
10/15/2014	Christopher Richard Anzalone	CEO	Buy	16,000	$6.32	$101,120.00
10/1/2014	Charles Mckenney	Director	Sell	2,500	$14.70	$36,750.00
9/30/2014	David L Lewis	Insider	Sell	15,000	$15.02	$225,300.00
9/26/2014	Douglas B Given	Director	Sell	2,000	$15.24	$30,480.00
6/9/2014	Charles Mckenney	Director	Sell	22,000	$14.32	$315,040.00
2/12/2014	Kenneth Allen Myszkowski	CFO	Sell	16,000	$18.77	$300,320.00
2/7/2014	Edward W Frykman	Director	Sell	3,148	$15.98	$50,305.04

(Data available from 1/1/2013 forward)

This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: How to Invest in an Index Fund

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Arrowhead Pharmaceuticals Insider Trades (NASDAQ:ARWR)

Adding

Adding

Adding Arrowhead Pharmaceuticals Inc

Insider Trades

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals (NASDAQ ARWR) Insider Trading History

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources